Archives
Preventing and treating the common cold: what’s the evidence?
22 Mar, 2022 | 08:56h | UTCPreventing and treating the common cold: what’s the evidence? – Evidently Cochrane
Commentary on Twitter
https://twitter.com/CochraneUK/status/1505978560078659587
Perspective | Teaching more about less: preparing clinicians for practice.
22 Mar, 2022 | 08:51h | UTCTeaching More About Less: Preparing Clinicians for Practice – The American Journal of Medicine (free for a limited period)
Viewpoint: Preparing clinicians for a clinical world influenced by artificial intelligence.
22 Mar, 2022 | 08:49h | UTCPreparing Clinicians for a Clinical World Influenced by Artificial Intelligence – JAMA (free for a limited period)
Study shows low risk of acute myocardial infarction after ophthalmologic procedures, confirming previous knowledge that preoperative evaluation may be unnecessary for most patients.
22 Mar, 2022 | 08:47h | UTCRisk for Acute Myocardial Infarction After Ophthalmologic Procedures – Annals of Internal Medicine (link to abstract – $ for full-text)
Summary for patients: Summary for Patients: Risk for Heart Attack After Eye Procedures
Editorial: Preoperative Evaluation Can Delay Ophthalmologic Surgery Without Improving Outcomes ($)
Commentary: Ophthalmologic Procedures Not Tied to Increased AMI Risk – HealthDay
Related:
Systematic Review: Routine Preoperative Medical Testing for Cataract Surgery
Commentary on Twitter
Ever had to do a pre-operative risk stratification prior to outpatient optho procedure? Have data to back up your rec? Now you have more 👇https://t.co/2wD7O6byuX
Inpatient #registry study from 🇳🇴&🇸🇪
>40y. 806 patients.
No association with ⬆️#AMI risk. #CardioTwitter
— Amitabh C. Pandey (@AmitabhCPandey) March 21, 2022
Guidelines on sickle cell disease: secondary stroke prevention in children and adolescents.
22 Mar, 2022 | 08:34h | UTC
Consensus Paper: Vitamin D and calcium intakes in general pediatric populations.
22 Mar, 2022 | 08:36h | UTC
Guideline Synopsis: The management of substance use disorders.
22 Mar, 2022 | 08:38h | UTC
Long-term longitudinal patterns of patient-reported fatigue after breast cancer: a group-based trajectory analysis.
22 Mar, 2022 | 08:29h | UTC
Commentary on Twitter
https://twitter.com/PTarantinoMD/status/1503916087829794816
Evaluation of glial and neuronal blood biomarkers compared with clinical decision rules in assessing the need for computed tomography in patients with mild traumatic brain injury.
22 Mar, 2022 | 08:33h | UTC
Commentary on Twitter
In this prospective cohort of mTBI/concussion patients, CCHR, NOC and blood test GFAP/UCH-L1 were equally sensitive in detecting traumatic intracranial lesions on CT but CCHR had the highest specificity; GFAP combined with CCHR detected lesions best. https://t.co/hYwxg76uu8
— JAMA Network Open (@JAMANetworkOpen) March 14, 2022
Editorial: Pig-to-human transplants take a leap toward reality.
22 Mar, 2022 | 08:31h | UTCPig-to-human transplants take a leap toward reality – Nature Medicine
RCT: Levothyroxine is not beneficial for euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss.
22 Mar, 2022 | 08:24h | UTCLevothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
Commentary: Levothyroxine No Boon for Birth Rates in Women With Possible Thyroid Disorder – MedPage Today (free registration required)
Enabling patient choice: the “deciding not to decide” option for older adults facing dialysis decisions.
22 Mar, 2022 | 08:25h | UTCCommentary: The “Deciding Not to Decide” Option Can Improve Older Adult Patient Care – Rutgers University-New Brunswick
Phase 2 trial of Iberdomide in systemic lupus erythematosus.
22 Mar, 2022 | 08:27h | UTCPhase 2 Trial of Iberdomide in Systemic Lupus Erythematosus – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Mixed Results for Oral Lupus Drug in Phase II— Mid-stage study offers hope but also reason for caution – MedPage Today (free registration required)
Commentary on Twitter
In patients with systemic lupus erythematosus, iberdomide at the highest dose, but not at lower doses, was superior to placebo with respect to the primary end point of an SRI-4 response at 24 weeks. https://t.co/rie3SRhoew pic.twitter.com/wRre5Gp1xB
— NEJM (@NEJM) March 17, 2022
Daytime napping and Alzheimer’s dementia: A potential bidirectional relationship.
22 Mar, 2022 | 08:14h | UTCCommentaries:
Long naps may be early sign of Alzheimer’s disease, study shows – The Guardian
Excessive daytime naps may be a sign of early cognitive decline – MedicalResearch
Outcomes and safety of history-based screening for medication abortion: a retrospective multicenter cohort study.
22 Mar, 2022 | 08:11h | UTCInvited Commentary: It Is Time to Change the Standard of Medication Abortion – JAMA Internal Medicine (free for a limited period)
RCT: Safety and efficacy of AGN-190584 in individuals with presbyopia.
22 Mar, 2022 | 08:20h | UTC
Commentary on Twitter
A new proprietary formulation of pilocarpine developed to treat presbyopia met its primary endpoint in the GEMINI phase 3 clinical trial, safely and effectively improving distance-corrected mesopic near vision for hours after eye drop instillation. https://t.co/WG5DZ6XQxZ pic.twitter.com/YXnW387R7i
— JAMA Ophthalmology (@JAMAOphth) March 4, 2022
Investigating cognition in midlife.
22 Mar, 2022 | 08:13h | UTCInvestigating cognition in midlife – Alzheimer’s & Dementia
Current management of urachal carcinoma: an evidence-based guide for clinical practice.
22 Mar, 2022 | 08:09h | UTC
Evidence-based disposition of acute pancreatitis.
22 Mar, 2022 | 08:08h | UTCEvidence-Based Disposition of Acute Pancreatitis – emDocs
Related Guidelines:
Pancreatitis – National Institute for Health and Care Excellence
The incidence of breast cancer recurrence 10-32 years after primary diagnosis.
22 Mar, 2022 | 08:12h | UTC
Vitamin B3, niacinamide and reducing skin cancer risk: what does the research say?
22 Mar, 2022 | 08:03h | UTC
Phase 2 RCT: Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy.
22 Mar, 2022 | 07:59h | UTC
Commentary on Twitter
In patients with late-stage Duchenne muscular dystrophy, CAP-1002 cell therapy appears safe & effective in reducing deterioration of upper limb & cardiac function, trial suggests. Longer-term extension studies needed.
Explore full findings: https://t.co/bCLtsbuJH3 pic.twitter.com/h7vareAMC7
— The Lancet (@TheLancet) March 21, 2022
Rapid point-of-care genotyping to avoid aminoglycoside-induced ototoxicity in neonatal intensive care.
22 Mar, 2022 | 08:01h | UTCEditorial: Genetic Testing in Newborns Moves From Rare to Routine Application
Commentary on Twitter
The MT-RNR1 m.1555A>G variant predisposes to profound aminoglycoside-induced ototoxicity
The MT-RNR1 POCT was able to genotype the m.1555A>G variant in 26 minutes. #IDTwitter #medtwitter #TwitteRx #MedEd #PIDTwitter https://t.co/BbkpNMiNHN— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) March 21, 2022
EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis.
21 Mar, 2022 | 10:01h | UTC
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity.
21 Mar, 2022 | 09:47h | UTC
Commentary on Twitter
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severityhttps://t.co/iFL1AD4q2l@pvmarkov, @ArisKatzourakis & Stilianakis argue that ongoing rapid antigenic evolution is likely to produce new variants that may escape immunity and be more severe. pic.twitter.com/BddNu5DZaq
— Nature Reviews Microbiology (@NatureRevMicro) March 14, 2022